%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-05-30T12:16-05:00
2017-05-30T12:16-05:00
2017-05-30T12:16-05:00
Adobe InDesign CC 2017 (Windows)
uuid:039fec1d-4dab-44ec-a36e-d9dc4ba3c5a5
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
xmp.id:d74f6568-9956-c34d-8219-3946694fe8df
proof:pdf
xmp.iid:bb871608-d11a-3541-bf66-142300e60397
xmp.did:38f09b08-0ad4-5546-bf75-c4adac64708c
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2017-05-30T12:16-05:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
23 0 obj
<>stream
BT
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0.04 Tc -0.04 Tw 9 0 0 9 48.189 32.9076 Tm
(58)Tj
0 Tc -0.037 Tw 8 0 0 8 48.189 681.5031 Tm
(4.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(R)40.5 (ocha )-0.7 (G, )-0.7 (Oliveira )54.8 (A, Queiroz D, )-0.7 (Mendes )-1.8 (E, Moura )-0.7 (S, Oliveira C, )]TJ
0.03 Tw 0 -1.2 TD
[(et )-1 (al. )-0.7 (Serodiagnosis of )0.6 (Helicobacter )-1.8 (pylori infection )-1.5 (by Cobas )]TJ
0.12 Tw T*
[(Core ELISA)55 ( )-0.7 (in )-1.2 (adults )-1.8 (from Minas )-1.9 (Gearais, )-1.9 (Brazil. )-0.6 (Braz J Med )]TJ
0 Tw T*
[(Biol R)40.6 (es 1998; 31\(10\): 1263-68.)]TJ
0.47 Tw -1.772 -1.2 Td
(5.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(W)45.8 (ex )17.9 (T)166.4 (, V)64 (enerit)-1.5 (o )0.6 (M, Kreutzer J, G\366tze )17.8 (T)166.5 (, Kandulski )54.1 (A, )]TJ
0.01 Tw T*
[(Malfertheiner )-2.5 (P)195.7 (. Serological )0.6 (P)47.2 (revalence )-1.5 (of )0.7 (Helicobacter )-1.8 (pylori )]TJ
0.268 Tw T*
[(Infection )-1.9 (in )-1 (Saxony-Anhalt, )-2.7 (Germany)120.7 (, )-0.7 (in )-0.9 (2010.Clin )-2.9 (V)78.2 (accine )]TJ
0 Tw T*
(Inmunol. 2011; 18\(12\): 2109-12.)Tj
0.37 Tw -1.772 -1.2 Td
(6.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Zhang )-1.1 (M, )-0.6 (Zhou)-0.7 ( )18 (Y)160.9 (, Li X, )18.3 (T)124.9 (ang)-0.7 ( Z, Zhu )-0.7 (H, )17.6 (Y)92.4 (ang )17.4 (Y)160.8 (, et )-0.9 (al. )]TJ
0.128 Tw T*
[(Seroepidemiology )-1.1 (of Helicobacter )-2.4 (pylori infection )-2 (in )-1.2 (elderly )]TJ
0.222 Tw T*
[(people )-0.6 (in the )-1.2 (Beijing )-0.7 (regi\363n, chin)-1.1 (a. W)45.8 (orld )0.7 (J )0.5 (Gastroentrol. )]TJ
0 Tw T*
(2014; 20\(13\): 3635-39.)Tj
0.02 Tw -1.772 -1.2 Td
(7.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(K)31.6 (im H, K)31.6 (im N, )-0.6 (K)31.6 (im S, Seo J, P)47.3 (ark E, Lee )-1.3 (D. )-0.7 (Seroprevalence )-1.5 (of )]TJ
0.009 Tw T*
[(Helicobacter )-1.6 (pylor)0.5 (i infection )-1.2 (in K)31.5 (orean Health )-1.7 (P)47.2 (ersonnel. )-0.6 (Gut )]TJ
0 Tw T*
[(and Liver)131.8 (. 2013; 7\(6\): 648-54.)]TJ
0.026 Tw -1.772 -1.2 Td
(8.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Alvarado-Esquivel C. )-0.6 (Seroepidem)-0.9 (iology of )0.5 (Helicobacter )-2 (pylori )]TJ
0.062 Tw T*
[(infection )-1.7 (in )-0.9 (P)47.3 (regnant )-2.1 (W)45.9 (omen )-0.9 (in )-0.9 (R)28.8 (ural )-0.7 (Durango, )-1.2 (Mexico. )-1.3 (Int )-1.6 (J )]TJ
0 Tw T*
(Biomed Sci. 2013; 9\(4\): 224-29.)Tj
0.26 Tw -1.772 -1.2 Td
(9.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Camargo )-0.6 (M, )-1.1 (Beltran )-1.6 (M, )-1.1 (Conde-G)-1.1 (lez C, )-0.8 (Harris P)195.7 (, )-0.6 (Michel )53.3 (A, )]TJ
-0.046 Tw T*
[(W)55.6 (aterboer )17.1 (T)166.5 (, et )-1.1 (al. )-0.6 (Serological response )-0.8 (to Helicobacter )-1.9 (pylori )]TJ
0.048 Tw T*
[(infection )-2 (among )-1 (Latin )53.2 (American )-1.7 (populations )-1.8 (with )-1.7 (contrasting )]TJ
0 Tw T*
[(risk of gastric c\341ncer)131.6 (. Int J Cancer)130.4 (. 2015; 137: 3000-5.)]TJ
0.026 Tw -1.772 -1.2 Td
(10.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Alvarado-Esquivel C. )-0.6 (Seroepidem)-0.9 (iology of )0.5 (Helicobacter )-2 (pylori )]TJ
0.113 Tw T*
[(in )17.2 (T)125 (epehuanos )53.4 (Aged )-0.6 (15 )16.9 (Y)104.7 (ears )-0.6 (and )-1.2 (Older in )-0.8 (Durango, )-1.2 (Mexico. )]TJ
0 Tw T*
[(Journal of P)47.5 (athogens. 2013; 1-5.)]TJ
0.249 Tw -1.772 -1.2 Td
(11.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(T)124.9 (adesse )-1.5 (E, Dak)-1.1 (a )-1 (D, )17 (Y)104.6 (emane )-2.3 (D, )-0.8 (Shimelis )16.5 (T)166.5 (. )-0.8 (Seroprevalence )]TJ
0.203 Tw T*
[(of Helicobacter )-2.2 (pylori infection )-1.9 (and )-1.4 (related )-2 (risk factors in )]TJ
0.296 Tw T*
[(symptomatic )-2.2 (pati)-1.1 (ents )-1.7 (in )-1.3 (southern )-1.8 (Ethiopia. )-1.8 (BMC )-1.2 (R)40.5 (esearch )]TJ
0 Tw T*
(Notes. 2014; 7\(1\): 834-38.)Tj
0.103 Tw -1.772 -1.2 Td
(12.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Jaka )-1.5 (H, )-0.9 (Mushi)-1.2 ( M, )-1 (Mirambo )-0.9 (M, )-1.1 (W)13.6 (ilson L, )-1 (Seni )-1.3 (J, Mtebe )-2.3 (M, )-1 (et )]TJ
0.224 Tw T*
[(al. Sero-prevalenc)-1.2 (e and )-0.8 (associated )-1.3 (factors of )0.7 (Helicobacter )]TJ
0.008 Tw T*
[(pylori infection )-2 (among )-1.1 (adult )-2 (patient )-3.1 (with )-1.8 (dispepsia )-1.7 (attending )]TJ
0.172 Tw T*
[(the )-1.8 (gastroenterology )-1.1 (unit )-1.9 (in )-1.1 (a )-0.9 (tert)-1.1 (iary )-0.9 (hospital )-1.4 (in )-1 (Mwanza, )]TJ
0 Tw T*
[(T)124.9 (anzania. )53 (African Health Sciences. 2016; 16\(3\): 684-9.)]TJ
0.357 Tw -1.772 -1.2 Td
(13.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(K)31.6 (ishikawa )-2.4 (H, )-1.1 (K)31.6 (imura )-1.3 (K, )17.6 (T)124.9 (akar)-0.8 (abe)-1 ( )-0.6 (S, )-0.7 (Kaida )-1.4 (S, )-0.7 (Nishida )-1.8 (J. )]TJ
0.602 Tw T*
[(Helicobacter )-1.9 (pylori )55.3 (Antibody )17 (T)42 (it)-0.7 (er and )-1.1 (Gastric )-1 (Cancer )]TJ
0 Tw T*
(Screening. Disease Markers. 2015; 1-11.)Tj
0.178 Tw -1.772 -1.2 Td
(14.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Lozano-P)47.4 (ope I,)-0.6 ( Sharma )54.3 (A, Matt)-1.8 (hias M, )-0.6 (Doran K, Obonyo M. )]TJ
0.172 Tw T*
[(Effect of )0.6 (myeloid )-0.7 (differentiation )-2.4 (primary response gene )-1.4 (88 )]TJ
0.101 Tw T*
[(on expression )-0.8 (profiles of genes )-1.4 (during )-0.9 (the )-1.7 (development )-2.1 (and )]TJ
0.482 Tw T*
[(progression )0.9 (of )0.8 (Helicobacter-induc)-3.1 (ed gastric cancer)132.2 (. BMC )]TJ
0 Tw T*
[(Cancer)132.2 (. 2017; 17\(1\):133.)]TJ
-0.008 Tw -1.772 -1.2 Td
(15.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Burkitt )-1.6 (M, )-0.7 (Duc)-0.8 (kworth )-0.8 (C, W)13.6 (illiam)-0.6 (s J, P)47.2 (ritchard )-1 (D. Helicobacter )]TJ
0.027 Tw T*
[(pylori-induced )-1.7 (gastric )-0.6 (pathology: )-0.9 (in)-0.6 (sights )-0.6 (from )0.9 (in )-0.6 (vivo )0.6 (and )-1 (ex )]TJ
0 Tw T*
(vivo models. Dis Model Mech. 2017; 10\(2\):89-104.)Tj
0.019 Tw -1.772 -1.2 Td
(16.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Herrero R, P)47.2 (ark )-0.7 (J, Forman D. )17.4 (The )-0.6 (fight )-0.9 (againts )-1.8 (gastric )-0.7 (c\341ncer )]TJ
0.146 Tw T*
[(\226 the )-1.1 (IARC )-0.7 (W)45.8 (orking Group report. Best )-0.9 (P)47.2 (ractice )-1.7 (& R)40.5 (esearch )]TJ
0 Tw T*
[(Clinical Gastroenterology)119.7 (. 2014; 28\(6\): 1107-14.)]TJ
0.558 Tw -1.772 -1.2 Td
(17.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(K)31.6 (oczula K, Gallotta )53.8 (A. Lateral )-2.1 (fl)0.5 (ow assays. )-1 (Essays in )]TJ
0 Tw T*
[(Biochemistry)121.1 (. 2016; 60\(1\): 111-20.)]TJ
0.345 Tw -1.772 -1.2 Td
(18.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Organizaci\363n )-1.1 (P)47.2 (anamericana )-3 (de la )-0.6 (Salud. )-1.2 (El c\341ncer )-1.3 (en )-1.1 (la )]TJ
0.222 Tw T*
[(regi\363n )-0.7 (de )-0.9 (las )54.6 (Am\351ricas. )-1.1 (OPS; 2012)-1.7 (. )-0.6 (Disponible )-1.5 (en: )-1.4 (http://)]TJ
0.003 Tc -0.003 Tw T*
[(ne)-0.6 (w)105.7 (.pah)-0.6 (o.org/)-0.6 (hq/in)-0.6 (de)-0.6 (x.php?opt)-0.6 (ion=com_docma)-0.6 (n&t)-0.6 (a)-0.6 (sk=)-0.6 (doc_)]TJ
0 Tc 0 Tw T*
(view&gid=16805&Itemid=.)Tj
0.169 Tw -1.772 -1.2 Td
(19.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Secretar\355a )-2 (de )-1 (Salud. )-1.3 (R)40.5 (egistro Histopatol\363gico de )-0.9 (Neoplasias )]TJ
0.608 Tw 0 -1.2 TD
[(Malignas. )-1.5 (Direcci)-1 (\363n General )53.8 (Adjunta )-1.6 (de Epidemiolog\355a. )]TJ
0 Tw 0 -1.2 TD
(M\351xico, 1993\2262004.)Tj
29.409 67.2 Td
(20.)Tj
-0.01 Tc 0.187 Tw /Span<>> BDC
7.68 0 0 8 308.9659 681.5031 Tm
( )Tj
EMC
0.37 0 Td
[(Uemura N, Okamoto S, )17.8 (Y)92.5 (amamoto S, Matsumura N, )17.8 (Y)92.5 (amaguchi)-10.1 ( )]TJ
0.331 Tw T*
[(S, )17.5 (Y)92.5 (amakido )-0.6 (M, et al. Helicobacter pylori infection )-0.6 (and the)-10.4 ( )]TJ
-0.05 Tw T*
[(development of gastric cancer)133.6 (. N Engl J Med. 2001; 345\(11\):784-9.)]TJ
0 Tc 0.503 Tw 8 0 0 8 297.6378 652.7031 Tm
(21.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Sachs )-0.7 (G, Scott )-0.8 (DR. Helicobacter)-1.8 ( pylori: Eradication )-1.3 (or )]TJ
0 Tw T*
[(P)47.3 (reservation. F1000 Med R)36.2 (ep. 2012; 4\(7\):7-12)]TJ
0.306 Tw -1.772 -1.2 Td
(22.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Ram\355rez-Ramo)-0.7 (s )54.8 (A, )-0.7 (S\341nchez-S\341nc)-2.3 (hez )-1 (R. )-0.9 (Helicobacter )-2.3 (pylori )]TJ
0.099 Tw T*
[(25 )-1.2 (a\361os despu\351s )-1.3 (\(1983 )-2.2 (-2008\): )-2.5 (Epidemiolog\355a, )-0.9 (Microbiolog\355a, )]TJ
0.443 Tw T*
[(P)47.3 (atogenia, )-2.5 (Diagn\363stico )-1.4 (y )17.4 (T)110.3 (ratamiento. )-2.7 (R)40.5 (ev )-0.6 (Gastroenterol )]TJ
0 Tw T*
[(P)47.3 (eru. 2009; 29\(2\):158-70.)]TJ
0.044 Tw -1.772 -1.2 Td
(23.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Ram\355rez )54.9 (A, Chinga )-0.9 (E, Mendoza )-1 (D. V)78.2 (ariaci\363n )-0.9 (de la prevalencia )]TJ
0.029 Tw T*
[(del H. pylori y su relaci\363n )-0.6 (con los )0.7 (niveles )-0.8 (de cloro )1.1 (en )-0.7 (el agua )]TJ
0.062 Tw T*
[(de )-1.2 (la )54.2 (Atarjea, )-1.7 (Lima, )-1.9 (P)47.3 (er\372. )-1.3 (P)47.2 (er\355odo 1985-2002. )-4.4 (R)40.5 (ev )-0.8 (Gastroent )]TJ
0 Tw T*
[(P)47.3 (er\372. 2004;24\(3\):223-9.)]TJ
0.387 Tw -1.772 -1.2 Td
(24.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Herrero R, )-0.9 (P)47.3 (ark )-1.2 (J, Forman )-0.7 (D. )16.8 (The )-1.1 (fight )-1.3 (against )-2.3 (gastric )]TJ
0.083 Tw T*
[(cancer )-0.9 (- the )-1.1 (IARC W)45.8 (orking Group report. Best P)47.2 (ract R)40.5 (es Clin )]TJ
0 Tw 0 -1.2 TD
(Gastroenterol. 2014;28\(6\):1107-14.)Tj
0.411 Tw -1.772 -1.2 Td
(25.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(P)47.3 (ilco C, P)47.3 (aye)-1 (t )-0.6 (M, )-0.8 (C\341ceres )-1.1 (G. )-0.6 (C\341ncer )-1.3 (G\341strico )-0.6 (en )-1 (Lima )]TJ
0 Tw 0 -1.2 TD
[(Metropolitana. R)37.9 (ev Gastroent P)45 (er\372. 2006;26\(4\):377-85.)]TJ
0.158 Tw -1.772 -1.2 Td
(26.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Ram\355rez )-0.9 (Ramos )54.8 (A, )-0.6 (Chinga )-1.9 (E, Men)-0.8 (doza D, )-1 (Leey )-1.9 (J, Guerra )-1.3 (J. )]TJ
0.005 Tw 0 -1.2 TD
[(Estudio )-0.7 (del )-0.8 (Helico)-0.6 (bacter )-1.7 (pylori en )-1.3 (el P)47.3 (er\372. )-1.2 (R)40.5 (ev )-0.7 ( P)47.2 (er )-0.6 ( Med )-1.6 ( Exp )]TJ
0 Tw T*
(Sal\372d P\372blica. 2002;19\(4\):209-214. \(En prensa\))Tj
0.021 Tw -1.772 -1.2 Td
(27.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Soto G, Bautis)-1.1 (ta )-0.8 (C, R)40.5 (oth D, Gilman )-0.7 (R, V)64 (elapati\361o )-1.8 (B, Ogura M, )]TJ
0.088 Tw 0 -1.2 TD
[(et )-0.9 (al. Helicobacter )-1.7 (pylori reinfection )-1.4 (is common in peruvian )]TJ
0.153 Tw 0 -1.2 TD
[(adults )-1.2 (fo)0.7 (llowing successful )-0.6 (antibiotic )-2.2 (eradication )-2.1 (therapy)120.5 (. J )]TJ
0 Tw 0 -1.2 TD
(Infect Dis.2003; 188 \(9\): 1263-75)Tj
-0.035 Tw -1.772 -1.2 Td
(28.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Ramirez-Ramo)-0.7 (s )55.3 (A, Gilman )-1.3 (R, Spira W)92.3 (, R)40.4 (ecavarren )-1.3 (S, W)55.7 (atanabe )]TJ
0.283 Tw T*
[(J, Le)-0.7 (on-Barua )-0.8 (R, et )-0.7 (al. Ecology )1.1 (of )0.5 (Helicobacter )-1.5 (pylori )0.5 (in )]TJ
0.253 Tw 0 -1.2 TD
[(P)47.3 (eru: infection )-0.9 (rates in coastal, )-0.6 (high )-0.6 (altitude, )-2.3 (and )-0.6 (jungla )]TJ
0 Tw 0 -1.2 TD
(communities. Gut. 1992; 33\(5\): 604-5. )Tj
-0.04 Tw -1.772 -1.2 Td
(29.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Ram\355rez Ramos )55.4 (A, Mendoza )-1 (R)40.5 (equ)-0.9 (ena )-1.2 (D, Leey )-1.3 (Casella )-0.9 (J, Guerra )]TJ
0.147 Tw 0 -1.2 TD
[(V)78.2 (alencia )-1.8 (J. Estudio del Helicobacter )-1.8 (pylori en )-0.8 (el P)47.3 (er\372. )-0.7 (R)40.5 (ev)134.1 (. )]TJ
0 Tw T*
[(P)47.3 (er\372. med. exp. salud p\372blica.2002; 19\(4\):209-14.)]TJ
0 1 0.65 0.47 k
/GS1 gs
/TT1 1 Tf
-1.772 -2.45 Td
(Fuentes de financiamiento:)Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0 -1.2 TD
(Este art\355culo ha sido financiado por los autores.)Tj
0 1 0.65 0.47 k
/GS1 gs
/TT1 1 Tf
0 -2.45 TD
(Conflictos de inter\351s:)Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0 -1.2 TD
(Los autores declaran no tener ning\372n conflicto de inter\351s.)Tj
0 1 0.65 0.47 k
/GS1 gs
/TT1 1 Tf
0 -2.45 TD
(Correspondencia:)Tj
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0 -1.2 TD
[(Arturo P)47.3 (areja Cruz)]TJ
0 -1.2 TD
[(Direcci\363n: )53.8 (A)55.3 (v)134.6 (. )54.7 (Alameda del Corregidor 1531. Urb. Los Sirius. Las )]TJ
0 -1.2 TD
[(V)17.7 (i\361as, La Molina.)]TJ
T*
[(T)124.9 (el\351fono: 998782686)]TJ
T*
(Correo electr\363nico: aparejac@usmp.pe)Tj
ET
0 1 0.65 0.47 k
/GS1 gs
330.236 192.706 170.079 36.851 re
f
BT
0 0 0 0 k
9 0 0 9 346.5532 213.3136 Tm
[(R)40.5 (ecibido: 24 de febrero de 2017)]TJ
0 -1.222 TD
(Aprobado: 16 de marzo de 2017)Tj
0 0 0 1 k
/GS0 gs
-0.02 Tc 8.82 0 0 9 114.1758 727.5375 Tm
(Seroprevalencia de infecci\363n por )Tj
/TT2 1 Tf
[(Helicobacter pylor)0.5 (i )]TJ
/TT0 1 Tf
[(en poblaci\363n adulta de Lima, P)47.2 (er\372 2017)]TJ
0 Tc 9 0 0 9 73.7008 32.9075 Tm
(Horiz Med 2017; 17\(2\): 55-58)Tj
ET
endstream
endobj
14 0 obj
<>
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
28 0 obj
<>
endobj
29 0 obj
<>stream
H\j }ܽXi.H,lƈq/uBOy=wF{n=zQ$mX^vq`'qL%W6=e=oNCM
'*2aFQv;Y"Ԍ\vsA&2
3Qyd$Dg&x#S .eccSS6quwթfjU*pC!42<܆G$f
0 $
endstream
endobj
30 0 obj
<>stream
HUy\TQPVI<3 R(3J:Î"`Jڠ§-eKY!2i[n; Om緝\ wBC""c.\/85FZJO(PWB25#?3wM9C!SՓtKڡӾ ^t`x_xA-(UͤT"%ހZ;N@'Zrӻo?L KϛR莽ySONpOE|A-jWG߰Vak1I<<J/>J͡}X(f %&0j# L:O?BN.\ݚh٪>CpHаNDFu{^
}MCK>bĤc_;lAJjZzFfV 9'MR0pZQqɫg̜U:9s^7
k\b?ު\+~VZfoظil.WعÏ>ɧ/|ޯv}wc?|gj֞ALK`54*jʪZZ:"5H8iI`Yy ޙG'ō|_7Gi:ijIRJm
Ԇjfm~~Mvە^*>V>)|J$⥱wk˹w${|i)|7N77M#O~gK;|t]cSԕUוnn٪ [yMckwnc6[@jFvYQSqFM^MbG <%?Ӈ`kzo܍r$
?$lي2Jױxa%R-,]'Wfm5 ېT,F!qG.#qc;2qK3~OU\lL@.r0IdLTpETx30XY) FɝZ$:C5tjIMNԒ<ȓՑ~tZQk"o.t~t5N
I6ݡ?.[ {tC'Gd'?6_p(ډ[I$fN̙'
dTtr Xs"b_)B#2wւd̓bQ8u|/c
>ԅ")
q$l8#)d>ԗbȈdXGqԟ@z`BC)Q
4Fa%%R1LXGfP
RSeRec )&R$LSR!M"*N֑#|!k
PϺ`9~^_R3!*ȜthlD`ҘsзEJ]۠ \9DǖmWsj.9dT&bKQ<`g"ICd&ec=/}#$PAH8H&WӉ0E,Wue[FCm%h7PmJ(+eKPm
ԉUAag>;N۞es=g7sO$':3!v?E7ZOo1zf\"fbisj]VSՑ0|Ke<`5kG&юh?K
W$kpMϥG͏j~d_T,2_'XT^Ohb;3]#mLbCa919 mb=-cv%&ٶ fSD"i,/[[Py
3RQxjtfL[[u;k3[ <1w`\`nɬ[dkf*hҚec<-2g9&[3oRkw832g#$,+}hh6@-xjVWl~WV{(˦elx-j~i;V,*pLRI\T)*`ƍ XҙſeKFԨ~F3| k܁Ll!n֪T0
#Llxƚ%'IنF, BIWJXISe%SvfS7$,^p78$ eK;8StfBz>P?pTWgm['oKUZ!ɹsuzNǫ λ)I3KAyfc6cG)
*F7' T\'].)ʹ.sKKn tR˅ +Q/l7Tj%>)N"WNS9VQؼD#<3FƸTuP[v{;~1~~cvc"W;)+'DF|GqRE>Mv(R㨃PwMFY6m+ZoǥI}c<ЫUC$P<}ʪkުw>DtE59 $xv
T]ƌjPH3\pvݦGF ӓ홸:Dzd:!16+fm6WƸ56>y4{Vhu+.v]_KJnM/|Ng'V,gswKa"dmv''~|_c]/%u^zmH`P?S}GX#0*1hАqˠ'ƍVc2$#P\i&1[I;FD3$Pk]]%ϖv qd1 `z,8T()
:þzvL~c>?xllk|ue^毰X96Q jDOz'TA^㼕pHw4N(ûSA_e]l/c+j\*zz=
"(#jZA2+ϑ9iq@i@Lףς,v|NG3RE2chk\܌гy߉}X i?9_~5Q*{
=㳃ȏp%A@pq/ٯ87s=Ȁl,)~ZyxT*`B6ś6_ľM
o6݀J -@쪚ROQU@;TeA6a:I#iE0?}> eKkȊ"H{IN$~ߒ}ȮE.Gg^
BPGU
y ԙH92Hd %T,aJҭ(hWPʈ2\S*nr4;ԙ-N
ɖyED[E͋sKi̘Bcܰw/+}/_ͯNA~?$}m.m@= j8
nb
\
Ht#*_T|PZbX&cSјFbU)>W4笴:N,K4V
25)7,Ν cEQ
3'@Y }/rE]wdፗKKwo=(늟eYVPIe}+R/䝢ನThP[kf|Z&ԄIRmM*6ƶVSIҘZm w/δ3q~{ι{AWǟudh//;7k\Hˌ_~wW5su{KɈ"ݷS˚i-V[5ee%ԭiEZք ]wpðX -226cf]-Vn-j=/'IWj4'05ʯXuvf?w9iҍsbV@5§gׄQf1^DCt` %zp9:;89"S#HylI$Ɇw
-KJXWFōc?RR[-/e*_p~/(xѳ)sڞsx
}Kx&ѹӵ,\-*R-FWb^Ui2dWvn
\#`n#vd
!-A{抛!HX Pem?i\s4\04$)}}Ω6,Uf-9Р8ب?ld--MX$Q[bu,$~v-
^eۨJ6)/G"[fvÒj%ݢDZ.PAR2x DOWAw /